ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
7,901
60.57999
1
female
1
4
4
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
2,080
1,654.6143
1,357.58984
10
white
26.699219
27
0.792969
0.667969
1
0
0
no
0.1
0.001
dnr after sadm
1
77
13.699219
106
22
35.5
null
3.299805
2.899902
1.099854
131
null
null
null
null
null
2
<2 mo. follow-up
2
7,902
70.10498
0
male
0
15
1,858
MOSF w/Malig
ARF/MOSF
1
8
>$50k
0
76,778
67,495.8125
43,702.6562
19.666656
white
17.097656
18
0.72998
0.646973
63
0
0
yes
null
null
no dnr
15
73
8.699219
118
24
38.59375
285.6875
null
null
1
143
7.479492
null
null
null
null
2
null
2
7,903
58.793
1
male
0
21
51
MOSF w/Malig
ARF/MOSF
2
11
$11-$25k
0
54,473
38,711.1562
34,905.0938
23.333328
white
28.398438
33
0.416992
0.296997
15
0
0
metastatic
null
null
dnr after sadm
1
77
35.09375
102
26
38.89844
129.0625
2.5
1.799805
0.599976
136
7.519531
null
null
null
null
null
<2 mo. follow-up
3.420898
7,904
75.13495
1
male
0
7
13
COPD
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
8,814
6,860.8555
6,942.03906
18
white
19.398438
19
0.820923
0.708984
1
0
0
no
0.95
0.7
dnr after sadm
1
85
null
107
24
36.19531
204
null
null
null
140
7.349609
null
null
null
null
2
<2 mo. follow-up
2
7,905
77.60394
1
male
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
under $11k
0
25,038
16,361.9688
17,482.7812
43.5
white
20.699219
38
0.797974
0.730957
2
0
0
no
null
null
dnr after sadm
2
63
10.398438
74
26
37.89844
265
null
1
2.699707
138
7.379883
null
null
null
null
4
<2 mo. follow-up
4
7,906
72.75
1
female
0
8
447
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
41
4,467
3,677.4961
2,880.95898
9.5
white
17.898438
10
0.75
0.60498
1
0
1
no
0.6
0.5
dnr after sadm
1
82
7.399414
60
24
36.79688
240
null
null
0.5
137
7.40918
null
null
null
null
5
adl>=4 (>=5 if sur)
5
7,907
97.26495
1
female
0
12
1,038
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
8,296
6,480.2188
5,072.75
13.5
white
16.796875
33
0.708984
0.549927
1
0
0
no
0.8
0.6
no dnr
12
113
12.5
110
40
36.09375
388
4.399414
0.399963
1
139
7.349609
null
null
null
null
6
adl>=4 (>=5 if sur)
6
7,908
75.31299
1
male
1
12
12
Lung Cancer
Cancer
2
8
$11-$25k
0
13,414
9,397.8672
7,863.01953
16
white
38.59375
38
0.109985
0.004
1
0
0
metastatic
0.51
0.2
dnr after sadm
1
76
5
122
28
36.09375
null
2.299805
0.899902
0.599976
132
null
null
null
null
null
5
<2 mo. follow-up
5
7,909
60.93399
1
female
0
5
306
COPD
COPD/CHF/Cirrhosis
1
12
$25-$50k
0
4,130
2,908.0137
2,926.44922
15
white
19
16
0.861938
0.770996
1
0
0
yes
0.95
0.75
dnr after sadm
2
102
6.899414
72
20
36.59375
347.5625
4
0.5
0.5
125
7.399414
null
null
null
null
2
no(M2 and SIP pres)
2
7,910
74.30298
0
male
0
10
1,849
COPD
COPD/CHF/Cirrhosis
1
null
null
0
6,503
4,888.7773
3,947.50977
13
white
15.898438
30
0.865967
0.777954
1
0
0
no
0.99
0.95
no dnr
10
102
8.798828
84
28
36.39844
264
null
null
1.199951
138
7.379883
null
null
null
null
null
null
2.767578
7,911
86.26398
1
female
0
8
1,466
CHF
COPD/CHF/Cirrhosis
3
null
null
0
3,748
3,288.6504
2,415.18945
9
white
17.796875
29
0.81897
0.705933
1
1
0
no
0.75
0.5
no dnr
8
110
7.099609
65
32
36.39844
null
3.399902
0.699951
1.199951
134
null
null
null
null
null
1
no(M2 and SIP pres)
1
7,912
63.017
0
male
0
11
1,848
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
26
51,051
null
null
33
white
20.398438
24
0.72998
0.646973
20
0
0
no
0.6
0.5
no dnr
11
127
8.898438
102
26
38.19531
200
3.199707
1.199951
0.699951
133
7.449219
null
null
null
null
null
no(M2 and SIP pres)
2.61084
7,913
78.073
1
male
0
5
1,664
COPD
COPD/CHF/Cirrhosis
1
8
null
0
4,193
3,009.7422
3,151.2793
20
white
22.097656
42
0.761963
0.621948
1
0
0
no
0.9
0.6
dnr after sadm
1
68
7.099609
122
40
36.19531
234.78125
3.449707
0.5
1
140
7.369141
null
null
null
null
1
no(M2 and SIP pres)
1
7,914
74.00397
1
female
0
18
217
Colon Cancer
Cancer
1
9
under $11k
0
8,549
7,534.168
7,275.88672
7.666664
white
8.099609
23
0.896973
0.763916
1
0
0
metastatic
0.5
0.1
no dnr
18
68
10.398438
71
24
37.29688
null
4
0.599976
1.099854
138
null
null
null
null
1
1
no(M2 and SIP pres)
1
7,915
57.51099
1
male
1
6
6
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
3,293
2,865.4961
2,124.48828
7
white
21.398438
23
0.86792
0.781982
1
0
0
no
null
null
no dnr
6
63
6.899414
57
20
35.69531
null
null
null
1.299805
130
null
null
null
null
1
2
<2 mo. follow-up
2
7,916
63.06897
0
female
0
17
1,845
CHF
COPD/CHF/Cirrhosis
4
null
null
0
13,703
10,648.0156
8,112.57812
7.666664
white
18.898438
20
0.87793
0.796997
1
1
0
no
0.9
0.5
no dnr
17
63
null
53
20
35.59375
null
null
null
1.199951
140
null
null
null
null
null
null
null
2.957031
7,917
71.90698
1
male
0
23
27
COPD
COPD/CHF/Cirrhosis
5
8
null
0
27,122
18,723.4531
17,011.8594
12
white
19.699219
34
0.794922
0.670898
1
1
0
yes
null
null
dnr after sadm
1
126
12
104
29
36.39844
220
3.799805
0.799927
1.399902
136
7.479492
null
null
null
null
4
<2 mo. follow-up
4
7,918
71.79498
0
male
0
5
1,840
COPD
COPD/CHF/Cirrhosis
1
13
$11-$25k
0
4,419
3,358.459
2,894.5
17
white
12.099609
34
0.907959
0.844971
1
0
0
no
null
null
no dnr
5
103
8
58
28
36.89844
null
4.799805
0.5
1.599854
145
null
null
null
null
0
0
no(M2 and SIP pres)
0
7,919
74.75397
1
female
1
48
48
Colon Cancer
Cancer
1
null
null
0
48,359
37,019.1875
32,157.1562
11.75
white
26
25
0.62793
0.315979
1
0
0
metastatic
null
null
dnr after sadm
37
64
7.099609
62
24
36.39844
null
2.899902
4.699219
0.899902
140
null
null
null
null
null
null
<2 mo. follow-up
2.674316
7,920
66.86096
0
male
0
38
1,838
Coma
Coma
2
null
null
61
63,139
41,355.1562
42,469.25
24.5
white
27.296875
40
0.28894
0.218994
1
0
0
no
0.1
0.001
no dnr
38
57
11.298828
116
36
40
276.625
2.699707
0.799927
0.599976
133
7.439453
null
null
null
null
0
no(M2 and SIP pres)
0
7,921
61.16898
1
female
0
56
60
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
133,465
89,469.875
94,790.4375
30.5
white
31.898438
38
0.622925
0.438965
21
1
0
no
0.5
0.3
dnr after sadm
32
145
11
154
24
39.59375
236.65625
2.199707
0.299988
0.599976
152
7.319336
null
null
null
null
5
null
5
7,922
80.76398
0
male
0
6
1,833
COPD
COPD/CHF/Cirrhosis
1
8
$11-$25k
0
3,553
2,823.6777
2,881.34961
16
white
16.796875
26
0.823975
0.713989
1
0
0
no
0.9
0.4
dnr after sadm
2
66
8.298828
118
24
36.09375
270.3125
4
0.899902
1
137
7.439453
null
null
null
0
null
null
0.4948
7,923
58.14099
1
female
0
16
41
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
22,293
17,607.4688
16,129.4766
19.666656
white
23.5
47
0.834961
0.778931
1
0
0
no
0.3
0.2
dnr after sadm
2
62
6.799805
132
40
40
252.375
3.799805
1.299805
1
140
7.519531
null
null
null
null
0
<2 mo. follow-up
0
7,924
50.74597
0
male
0
4
1,832
COPD
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
2,421
1,880.4121
1,710.12988
8
white
18.199219
15
0.925903
0.875
1
0
0
no
0.85
0.85
no dnr
4
77
8.699219
98
20
36.79688
183.3125
null
null
1
142
7.439453
null
null
null
0
null
no(M2 and SIP pres)
0.4948
7,925
71.28296
1
male
0
3
139
Lung Cancer
Cancer
2
12
$25-$50k
0
4,032
3,012.9531
2,722.98828
27
white
16.097656
27
0.710938
0.429993
1
0
0
metastatic
0.5
0.2
dnr after sadm
2
65
null
79
28
38
182.5
null
null
null
140
7.429688
null
null
null
null
2
adl>=4 (>=5 if sur)
2
7,926
64.74194
0
female
0
35
1,830
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
$11-$25k
0
66,579
44,250.1562
44,276.0938
35.5
white
35
60
0.593994
0.485962
1
1
0
no
null
null
no dnr
35
127
10.199219
104
42
39.19531
84
2.5
3.399902
2.099609
137
7.399414
null
null
null
null
0
no(M2 and SIP pres)
0
7,927
83.05798
1
male
0
8
39
CHF
COPD/CHF/Cirrhosis
4
null
null
0
3,829
3,359.2793
2,520.75977
5.5
white
23.597656
33
0.74292
0.594971
1
0
0
no
0.9
0.9
no dnr
8
101
11.398438
60
24
35.69531
null
null
0.5
2.099609
133
null
null
null
null
null
null
<2 mo. follow-up
3.918457
7,928
62.37399
1
male
0
5
7
Lung Cancer
Cancer
2
null
null
9
2,110
1,810.6055
1,562.84961
5
white
21
29
0.588989
0.268982
1
0
0
metastatic
null
null
dnr before sadm
-1
73
15
114
10
35.89844
null
3.599609
0.299988
0.899902
127
null
null
null
null
null
null
<2 mo. follow-up
2.416016
7,929
85.15796
1
male
0
20
99
ARF/MOSF w/Sepsis
ARF/MOSF
1
5
$11-$25k
0
15,484
12,240.1953
9,871.42969
19
white
27.398438
49
0.658936
0.560913
1
0
0
no
0.5
0.4
no dnr
20
73
11.699219
115
32
38
190
3.699707
0.899902
2.299805
136
7.459961
null
null
null
1
2
no(M2 and SIP pres)
2
7,930
74.31097
1
male
1
8
8
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
16,942
11,618.4844
11,960.1094
32
white
29.5
51
0.631958
0.529907
3
0
0
no
0.1
0.001
dnr after sadm
5
72
12.099609
116
42
38.19531
192.5
3.599609
0.699951
2.099609
131
7.40918
null
null
null
null
null
<2 mo. follow-up
2.657227
7,931
60.78299
1
female
0
14
52
Lung Cancer
Cancer
1
12
null
0
9,817
7,615.7344
6,641.13672
10
white
25.199219
17
0.525879
0.203979
1
0
0
metastatic
null
null
no dnr
14
96
11.398438
118
16
37
280.9375
null
null
0.5
130
7.469727
null
null
null
1
3
<2 mo. follow-up
3
7,932
63.41397
1
female
0
13
66
Lung Cancer
Cancer
2
8
under $11k
26
10,723
7,882.6562
6,968.05859
17
white
24.296875
45
0.409973
0.109985
1
1
0
metastatic
0.6
0.1
dnr after sadm
1
112
13.898438
174
28
36
285.6875
null
null
1.299805
139
7.419922
null
null
null
null
1
adl>=4 (>=5 if sur)
1
7,933
58.22897
1
male
1
6
6
Lung Cancer
Cancer
2
null
null
26
3,920
3,139.7871
2,740.88867
14
white
26.898438
17
0.350952
0.074997
1
0
0
metastatic
null
null
dnr after sadm
1
75
8.599609
81
28
36.39844
null
2.599609
1.299805
0.799927
136
null
null
null
null
null
null
<2 mo. follow-up
2.911621
7,934
61.42398
0
male
0
13
1,827
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
16,383
12,483.0938
11,589.3984
23
white
21.5
15
0.849976
0.797974
1
0
0
no
0.9
0.9
no dnr
13
109
6
46
24
35.89844
313.3125
3.899902
0.299988
0.699951
141
7.379883
null
null
null
null
0
no(M2 and SIP pres)
0
7,935
74.52698
1
female
0
13
92
CHF
COPD/CHF/Cirrhosis
3
20
$11-$25k
0
7,505
6,412.2891
4,423.34766
10.5
white
18.199219
38
0.816895
0.702881
1
0
0
yes
null
null
no dnr
13
59
10.199219
76
14
36.29688
null
null
null
1.5
134
7.589844
null
null
null
0
1
adl>=4 (>=5 if sur)
1
7,936
70.78699
1
male
0
6
129
Lung Cancer
Cancer
3
8
null
0
3,736
2,807.2519
2,294.21875
18
white
21.199219
35
0.599976
0.281982
1
0
0
metastatic
0.5
0.25
dnr after sadm
1
68
14.099609
69
32
36.29688
null
null
null
1.5
132
null
null
null
null
null
0
null
0
7,937
40.17798
0
male
0
25
1,825
CHF
COPD/CHF/Cirrhosis
2
18
null
0
14,033
12,213.4141
8,536.73438
9.75
white
25.199219
22
0.876953
0.795898
1
0
0
no
null
null
no dnr
25
59
10
98
20
36.69531
null
2.799805
0.699951
1.199951
128
null
null
null
null
null
2
no(M2 and SIP pres)
2
7,938
63.439
1
female
0
9
15
CHF
COPD/CHF/Cirrhosis
5
null
null
0
10,268
8,213.5078
8,644.08594
6
white
32.59375
41
0.599976
0.41095
1
1
0
yes
0.5
0.2
dnr after sadm
3
66
12.798828
104
28
35.29688
null
null
null
1.899902
124
null
null
null
null
null
null
<2 mo. follow-up
3.602539
7,939
56.99399
0
male
0
7
1,823
COPD
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
3,978
3,115.3379
2,650.6582
12
white
18.796875
34
0.904907
0.839966
1
0
0
no
0.9
0.8
dnr after sadm
2
59
17.898438
93
24
35.69531
284
4.199219
0.5
1.899902
135
7.419922
null
null
null
1
0
no(M2 and SIP pres)
0
7,940
56.68399
1
male
0
9
11
Lung Cancer
Cancer
1
11
$25-$50k
0
7,076
5,450.5039
4,836.07812
9.5
white
24.898438
29
0.545898
0.222992
1
0
0
metastatic
null
null
dnr after sadm
1
69
18.199219
122
26
38.59375
176.65625
null
null
0.799927
136
7.369141
null
null
null
2
null
<2 mo. follow-up
1.839
7,941
63.23099
1
male
0
5
1,250
CHF
COPD/CHF/Cirrhosis
4
null
null
0
2,849
2,504.1836
2,060.84961
5
white
13.398438
19
0.918945
0.863892
1
1
0
no
0.9
0.8
no dnr
5
82
7.5
65
24
36.19531
null
3.899902
0.799927
1.299805
140
null
null
null
null
null
null
null
2.006836
7,942
51.49597
1
male
0
8
69
Cirrhosis
COPD/CHF/Cirrhosis
6
12
null
0
8,660
7,003.3945
5,817.53906
10.5
white
17.699219
32
0.824951
0.715942
1
0
0
yes
0.9
0.4
no dnr
8
68
8
79
15
36.29688
null
2.099609
3
1.099854
132
null
null
null
null
2
4
no(M2 and SIP pres)
4
7,943
75.422
1
male
0
12
755
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$25-$50k
0
18,862
13,873.7031
12,176.0391
24
white
26
47
0.680908
0.586914
6
1
0
no
0.9
0.8
no dnr
12
53
15.5
78
20
38.19531
107.5
null
null
1.199951
139
7.459961
null
null
null
0
null
no(M2 and SIP pres)
0.4948
7,944
63.88797
1
male
0
9
155
Lung Cancer
Cancer
2
10
$11-$25k
0
4,809
3,962.3945
3,805.23828
7.5
white
15.099609
15
0.745972
0.483948
1
0
0
metastatic
null
null
dnr after sadm
1
81
null
77
12
36.89844
null
null
null
1.199951
141
null
null
null
null
null
0
no(M2 and SIP pres)
0
7,945
73.89996
0
male
0
14
1,818
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
23,842
16,305.4531
17,274.6094
32.333313
white
24.796875
49
0.746948
0.600952
1
1
0
no
0.5
0.4
no dnr
14
78
12.599609
106
26
38.59375
80
2.899902
1.099854
1.199951
139
7.469727
null
null
null
null
1
adl>=4 (>=5 if sur)
1
7,946
73.19098
1
male
0
4
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
34,609
26,301.4688
23,111.4062
22
white
27.699219
30
0.553955
0.440979
14
0
0
yes
null
null
dnr after sadm
1
103
16
82
36
39.19531
94.65625
null
null
0.599976
137
7.429688
null
null
null
null
null
<2 mo. follow-up
2.137695
7,947
71.37598
1
male
0
14
285
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
9
16,882
12,369.4453
12,698.8438
18
white
33.5
43
0.539917
0.34198
1
0
1
no
0.1
0.001
dnr after sadm
1
77
24.5
106
28
36.19531
288
2.899902
0.799927
4.699219
133
7.359375
null
null
null
null
6
adl>=4 (>=5 if sur)
6
7,948
60.931
1
male
1
4
4
Lung Cancer
Cancer
2
null
null
26
2,094
1,653.3262
1,407.85938
12
white
28.597656
41
0.289978
0.045998
1
1
0
metastatic
null
null
dnr after sadm
1
56
18.898438
126
24
36.39844
319
3.199707
1.399902
1.299805
143
7.379883
null
null
null
null
null
<2 mo. follow-up
2.944824
7,949
58.75198
1
male
0
4
109
Lung Cancer
Cancer
4
12
null
0
1,401
1,250.9248
1,065.85938
4
white
13.798828
18
0.777954
0.536987
1
0
0
metastatic
null
null
no dnr
4
65
6.5
114
20
36
null
4.099609
0.599976
1.099854
133
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
7,950
73.69196
1
male
0
5
30
COPD
COPD/CHF/Cirrhosis
4
8
$11-$25k
0
8,756
6,566.4023
6,206.01953
22
white
22.097656
43
0.684937
0.516968
7
0
0
yes
0.9
0.61
no dnr
5
69
16.597656
160
28
38.5
297.125
3.699707
0.199982
1
130
7.389648
null
null
null
1
0
<2 mo. follow-up
0
7,951
67.68195
1
male
0
5
500
Lung Cancer
Cancer
2
16
>$50k
0
2,699
2,069.0703
1,551.36914
9
white
14.599609
23
0.746948
0.485962
1
0
0
metastatic
0.9
0.5
no dnr
5
65
6.099609
101
24
35.79688
null
4
0.399963
0.899902
131
null
null
null
null
2
null
no(M2 and SIP pres)
1.839
7,952
66.57599
1
female
0
11
17
CHF
COPD/CHF/Cirrhosis
3
10
null
0
16,643
14,302.6328
12,509.9062
35
white
12.798828
16
0.917969
0.860962
1
1
0
no
0.3
0.3
no dnr
11
72
null
68
24
36.39844
306.625
4
1.299805
0.899902
135
7.5
null
null
null
1
3
<2 mo. follow-up
3
7,953
57.46698
1
female
0
27
122
Cirrhosis
COPD/CHF/Cirrhosis
2
8
under $11k
0
26,240
19,473.25
21,596.9531
13.25
white
18.097656
29
0.829956
0.7229
1
1
0
no
0.95
0.85
no dnr
27
74
8.099609
87
20
36.69531
596.25
2.799805
1.899902
1.699951
134
7.369141
null
null
null
5
4
no(M2 and SIP pres)
4
7,954
57.75998
1
female
0
24
743
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
26
34,429
26,154.9844
23,527.6875
25.666656
white
26.296875
28
0.623901
0.519897
3
0
0
yes
0.7
0.6
no dnr
24
119
11.398438
150
28
36.39844
222.4375
3.399902
0.399963
0.599976
133
7.399414
null
null
null
null
0
no(M2 and SIP pres)
0
7,955
82.56299
1
female
1
4
4
Coma
Coma
0
null
null
94
3,348
2,935.7285
2,534.5
18
white
23.296875
14
0.106995
0.064987
1
0
0
no
0.05
0.000125
dnr after sadm
2
123
13.099609
59
24
39
114
null
null
0.899902
141
7.429688
null
null
null
null
null
<2 mo. follow-up
2.734863
7,956
61.27298
1
male
0
5
503
Lung Cancer
Cancer
4
16
>$50k
0
2,824
2,126.25
1,740.51953
9
white
5.399414
12
0.87793
0.724976
1
0
0
metastatic
0.75
0.4
no dnr
5
79
9.298828
83
20
36.89844
null
4.199219
0.199982
0.899902
137
null
null
null
null
0
0
no(M2 and SIP pres)
0
7,957
46.44498
1
female
0
5
78
Cirrhosis
COPD/CHF/Cirrhosis
3
null
null
0
3,171
2,591.4394
2,048.11914
19
white
18.296875
23
0.872925
0.78894
1
0
0
no
0.8
0.7
no dnr
5
83
7.599609
76
20
36.79688
null
2.399902
6
1.099854
136
null
null
null
null
null
null
null
2.130371
7,958
77.46698
1
female
0
15
261
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
10,748
8,356.8438
7,587.4375
9.333328
white
18.699219
45
0.836914
0.781982
1
1
0
no
0.95
0.9
dnr after sadm
1
67
11.599609
104
32
38.09375
285.6875
4.099609
0.899902
1
139
7.319336
null
null
null
2
4
no(M2 and SIP pres)
4
7,959
74.86694
0
female
0
5
1,802
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
0
2,715
2,189.9961
1,840.59961
8
white
17.5
39
0.846924
0.747925
1
0
0
no
0.9
0.8
no dnr
5
77
12.898438
71
32
36.39844
233.3125
null
null
0.899902
139
7.379883
null
null
null
0
1
no(M2 and SIP pres)
1
7,960
78.297
1
male
0
14
1,063
ARF/MOSF w/Sepsis
ARF/MOSF
1
3
under $11k
9
12,855
9,787.6484
8,389.22656
7.333332
white
22.199219
39
0.706909
0.61792
1
0
0
yes
null
null
no dnr
14
147
11.398438
110
42
36.79688
240
3.599609
0.399963
1.299805
140
7.399414
null
null
null
null
0
no(M2 and SIP pres)
0
7,961
70.14099
1
male
1
13
13
COPD
COPD/CHF/Cirrhosis
2
null
null
100
17,808
14,600.1484
11,584.5078
44.5
white
37.398438
75
0.049995
0.004999
1
0
0
no
0.05
0.000125
dnr after sadm
9
41
4.599609
122
44
39.69531
309.0625
null
0.699951
14
130
7.05957
null
null
null
null
null
<2 mo. follow-up
4.21875
7,962
81.19098
1
female
0
11
99
CHF
COPD/CHF/Cirrhosis
2
null
null
0
6,344
5,242.9648
4,108.64844
9.5
white
29.097656
50
0.639893
0.459961
1
0
0
no
0.6
0.4
dnr after sadm
1
51
33.695313
73
28
35
295.1875
null
null
1.299805
135
7.5
null
null
null
0
null
null
0.4948
7,963
68.69299
1
male
1
7
7
Cirrhosis
COPD/CHF/Cirrhosis
0
12
null
0
11,160
7,682.8633
8,087.65625
19
white
21.699219
29
0.704956
0.542969
1
0
0
no
0.8
0.75
dnr after sadm
6
103
12.099609
104
34
37.89844
250
2.5
1
1.699951
149
7.439453
null
null
null
null
1
<2 mo. follow-up
1
7,964
72.35596
0
female
0
32
1,798
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
9
88,405
58,013.2188
54,539.2812
35.5
white
24.5
39
0.671997
0.576904
12
1
0
no
0.2
0.1
no dnr
32
60
26.699219
160
8
39.39844
191.09375
2.699707
0.699951
1.199951
148
7.459961
null
null
null
null
2
adl>=4 (>=5 if sur)
2
7,965
68.68396
1
male
1
7
7
Cirrhosis
COPD/CHF/Cirrhosis
4
12
under $11k
9
4,790
3,761.4238
3,532.36914
7.5
white
30.5
52
0.35498
0.164978
1
0
0
yes
0.1
0.001
dnr before sadm
-1
72
13.398438
110
26
36.5
null
2.199707
1.599854
6.199219
129
null
null
null
null
null
0
<2 mo. follow-up
0
7,966
77.26794
1
female
0
3
710
Lung Cancer
Cancer
2
null
null
0
1,990
1,382.8867
1,067.67969
11
white
16.796875
10
0.682983
0.387939
1
0
0
metastatic
0.6
0.25
no dnr
3
81
null
76
20
35.79688
null
null
null
0.699951
140
null
null
null
null
null
null
null
2.374512
7,967
69.02399
1
male
0
9
15
Cirrhosis
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
5,258
4,392.2266
3,594.88867
9.5
white
21.796875
32
0.700928
0.537964
1
0
0
no
0.2
0.5
dnr after sadm
5
114
12.398438
106
24
38
414.25
2.699707
3.199707
1.699951
136
7.529297
null
null
null
null
7
<2 mo. follow-up
7
7,968
63.39499
1
male
0
7
810
CHF
COPD/CHF/Cirrhosis
2
12
null
0
3,169
2,724.1191
2,163.16992
12
white
17.5
26
0.888916
0.814941
1
0
0
no
null
null
no dnr
7
69
7.399414
76
24
36
null
null
null
1.5
134
null
null
null
null
null
null
no(M2 and SIP pres)
1.84082
7,969
62.63898
1
male
0
4
735
MOSF w/Malig
ARF/MOSF
1
12
under $11k
0
18,106
12,157.1406
10,354.3359
16
white
17.097656
21
0.755981
0.677979
15
0
0
yes
0.6
0.5
no dnr
4
111
8.199219
65
24
35.79688
328
null
null
1.5
139
7.379883
null
null
null
0
0
no(M2 and SIP pres)
0
7,970
75.75598
1
female
0
14
1,143
CHF
COPD/CHF/Cirrhosis
3
10
$11-$25k
0
9,652
8,003.9648
6,383.47656
10.666664
white
21.296875
39
0.765991
0.62793
1
0
0
yes
null
null
no dnr
14
65
15.599609
93
20
36.19531
206.65625
4.299805
0.799927
2.299805
130
7.489258
null
null
null
0
null
no(M2 and SIP pres)
0.4948
7,971
45.021
0
female
0
26
1,795
Cirrhosis
COPD/CHF/Cirrhosis
3
12
under $11k
0
39,258
30,343.0781
28,235.6094
17.5
white
25.796875
36
0.787964
0.659912
1
0
0
no
0.8
0.6
no dnr
26
65
19
130
12
36.19531
226
2.399902
4
1
147
7.439453
null
null
null
6
null
no(M2 and SIP pres)
4.527397
7,972
79.47198
1
male
0
8
228
Colon Cancer
Cancer
1
4
under $11k
0
6,229
4,599.8047
3,860.43945
14.5
white
15.199219
20
0.814941
0.602905
1
0
0
metastatic
0.5
0.2
dnr after sadm
1
68
7.799805
78
22
35.79688
null
null
0.399963
0.899902
138
null
null
null
null
5
null
no(M2 and SIP pres)
3.855299
7,973
82.91895
1
male
0
8
738
CHF
COPD/CHF/Cirrhosis
4
null
$25-$50k
0
6,971
null
null
12
white
25.898438
38
0.698975
0.535889
1
1
0
no
0.5
0.3
no dnr
8
70
15.699219
102
12
36.59375
114
3.899902
0.699951
1.599854
139
7.369141
null
null
null
0
0
no(M2 and SIP pres)
0
7,974
61.24298
0
male
0
17
1,795
MOSF w/Malig
ARF/MOSF
1
13
$11-$25k
9
22,190
15,718.0469
14,078.2188
19.333328
white
27.699219
36
0.581909
0.471985
1
0
0
yes
0.9
0.9
no dnr
17
113
10.798828
46
24
35.69531
null
3.199707
0.399963
2.5
132
null
null
null
null
null
1
no(M2 and SIP pres)
1
7,975
71.72095
1
male
0
12
757
Colon Cancer
Cancer
1
12
under $11k
9
13,773
9,978.6094
8,378.07812
18.5
white
7.299805
21
0.892944
0.755981
1
0
0
metastatic
0.8
0.6
no dnr
12
71
6.799805
60
20
35.59375
null
4.399414
0.599976
1.199951
140
null
null
null
null
null
1
no(M2 and SIP pres)
1
7,976
54.366
1
male
0
7
18
Lung Cancer
Cancer
2
null
null
0
4,439
3,419.9531
3,195.09961
4
white
7.799805
10
0.862915
0.692993
1
0
0
metastatic
0.5
0.05
dnr after sadm
1
106
11.599609
73
20
36.19531
null
4.299805
0.399963
0.799927
135
null
null
null
null
null
null
<2 mo. follow-up
2.467773
7,977
85.36896
1
female
1
6
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
5,435
3,947.9746
3,281.05859
20
white
23
50
0.715942
0.628906
1
0
0
no
0.1
0.001
dnr after sadm
3
67
8.099609
72
44
38.19531
134.28125
3.899902
1.399902
1.399902
153
7.269531
null
null
null
null
null
<2 mo. follow-up
2.605957
7,978
71.12897
1
male
0
6
396
Lung Cancer
Cancer
2
6
under $11k
0
3,305
2,610.459
2,755.57812
13
white
19.898438
32
0.628906
0.317993
1
0
0
metastatic
null
null
no dnr
6
118
null
81
36
35.69531
null
null
null
1.599854
138
null
null
null
null
null
null
null
3.232422
7,979
43.12097
1
male
1
11
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
0
25,591
16,153.5859
18,159.7188
36.5
white
22.597656
43
0.866943
0.820923
3
0
0
no
0.4
0.5
no dnr
11
148
6
160
42
39
340
2.599609
0.399963
0.899902
144
7.40918
null
null
null
null
1
<2 mo. follow-up
1
7,980
59.715
0
female
0
11
1,783
CHF
COPD/CHF/Cirrhosis
3
8
null
0
15,675
12,458.0078
10,295.7891
13
white
24.796875
34
0.768921
0.631958
11
1
0
no
0.75
0.7
no dnr
11
101
13.5
96
20
36.29688
161.21875
3.899902
0.5
2.799805
136
7.399414
null
null
null
1
null
no(M2 and SIP pres)
1.1669
7,981
75.25299
1
male
0
4
1,224
Lung Cancer
Cancer
1
5
null
0
1,982
1,703.4512
1,200.72949
15
white
16.699219
22
0.688965
0.396973
1
0
0
metastatic
0.5
0.2
no dnr
4
98
4.599609
79
24
35.09375
null
3.699707
0.699951
1.5
135
null
null
null
null
null
null
no(M2 and SIP pres)
2.118652
7,982
81.85895
1
male
1
8
8
Coma
Coma
2
null
null
100
30,573
22,404.1562
20,921.7344
43
white
18.199219
29
0.074997
0.042
7
0
0
yes
0
0
dnr after sadm
5
134
11.699219
120
10
38
266.625
3.099609
0.5
1.199951
140
7.5
null
null
null
null
null
<2 mo. follow-up
3.027832
7,983
58.30499
0
male
0
6
1,777
Lung Cancer
Cancer
1
12
$25-$50k
0
4,919
3,350.6582
2,425.60938
10
white
6.599609
17
0.870972
0.709961
1
0
0
metastatic
null
null
no dnr
6
101
4.199219
76
22
35.89844
null
4.299805
0.699951
1.199951
136
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
7,984
66.99194
1
male
0
12
289
Coma
Coma
1
null
null
0
7,107
5,761.1719
5,130.54688
10
white
17.796875
22
0.67688
0.620972
1
0
0
metastatic
0.8
0.05
dnr after sadm
1
101
12.099609
71
24
35.59375
261.875
3.699707
0.699951
0.899902
137
7.479492
null
null
null
null
null
null
2.308106
7,985
73.63397
1
male
0
19
1,018
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
11,955
9,600.3672
7,533.54688
9
white
27.597656
43
0.711914
0.623901
1
0
1
no
0.95
0.95
no dnr
19
66
25.296875
104
28
38.79688
142.84375
4
1
1.099854
130
7.519531
null
null
null
null
null
null
4.679688
7,986
68.45398
1
female
1
22
22
Coma
Coma
2
null
null
55
31,886
27,470.5625
22,788.8281
24.666656
white
23.398438
39
0.371948
0.29895
3
0
0
no
null
null
dnr after sadm
3
50
5.399414
72
10
37.89844
330
2.699707
2.399902
1.899902
137
7.439453
null
null
null
null
null
<2 mo. follow-up
2.250488
7,987
79.04395
1
male
0
15
1,184
ARF/MOSF w/Sepsis
ARF/MOSF
1
7
under $11k
0
14,976
11,266.9609
8,886.63281
7.333332
white
19.898438
30
0.794922
0.726929
3
1
0
no
0.95
0.9
no dnr
15
103
16.199219
104
28
38.59375
null
null
null
1.299805
136
null
null
null
null
1
1
null
1
7,988
84.89795
1
male
0
20
24
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
under $11k
0
58,625
39,888.9688
40,975.3125
30
white
31.398438
41
0.445984
0.326965
20
0
0
no
0.5
0.4
dnr before sadm
-13
70
21.296875
130
10
35.79688
113.32812
3.199707
1.299805
1.399902
140
7.469727
null
null
null
null
2
<2 mo. follow-up
2
7,989
71.685
0
male
0
62
1,771
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
0
157,606
118,813.875
98,656.1875
34.5
white
26.097656
44
0.67395
0.578979
13
0
0
no
0.6
0.58
no dnr
62
56
22.597656
122
10
38.69531
262.5
3
2.199707
1.599854
145
7.459961
null
null
null
null
null
null
2.273926
7,990
64.24597
1
female
0
10
117
Lung Cancer
Cancer
3
12
under $11k
0
6,996
5,719.0234
7,208.16797
11.5
white
20.699219
29
0.630981
0.31897
1
1
0
metastatic
0.6
0.5
no dnr
10
70
6.399414
130
28
38.59375
null
3.599609
0.299988
0.699951
132
null
null
null
null
null
1
no(M2 and SIP pres)
1
7,991
59.26099
1
male
0
3
107
ARF/MOSF w/Sepsis
ARF/MOSF
3
16
>$50k
0
2,339
1,853.75
1,908.63965
19
white
23.097656
33
0.836914
0.781982
1
0
0
no
null
null
no dnr
3
55
7.799805
76
20
36.09375
null
4.199219
1.599854
1.5
129
null
null
null
null
6
null
no(M2 and SIP pres)
4.527397
7,992
70.43695
0
male
0
7
1,769
CHF
COPD/CHF/Cirrhosis
2
4
null
0
4,158
3,417.3438
2,814.97852
10
white
14.599609
15
0.896973
0.827881
1
0
0
no
0.9
0.6
no dnr
7
82
8.298828
63
24
35.89844
385.6875
4.099609
0.699951
1.199951
132
7.429688
null
null
null
0
null
no(M2 and SIP pres)
0.4948
7,993
74.85596
1
female
0
10
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
26
11,499
7,894.8828
5,474.85938
8
white
33.296875
62
0.448975
0.328979
1
0
0
no
0.3
0.2
dnr after sadm
1
73
0.899902
82
28
36.19531
347.5625
2.899902
6.5
1.699951
133
7.429688
null
null
null
4
7
<2 mo. follow-up
7
7,994
51.23099
1
female
1
94
94
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
144,148
137,408.625
134,868.375
35.5
white
32.796875
68
0.553955
0.440979
16
0
0
yes
0.6
0.6
dnr after sadm
92
149
7.299805
112
40
38.89844
110
2.299805
1
2.599609
148
7.429688
null
null
null
null
4
null
4
7,995
78.57397
1
male
0
10
1,524
COPD
COPD/CHF/Cirrhosis
1
8
null
0
6,569
5,492.7266
6,386.76953
15
white
26.199219
49
0.679932
0.509888
1
0
0
no
0.7
0.5
no dnr
10
109
7
120
32
36
280.9375
4
0.299988
2.899902
131
7.359375
null
null
null
0
0
no(M2 and SIP pres)
0
7,996
42.88599
1
female
0
6
240
Colon Cancer
Cancer
1
16
$25-$50k
0
2,807
2,326.2715
1,821.81934
11
white
1.5
21
0.955933
0.894897
1
0
0
metastatic
0.8
0.5
no dnr
6
62
2.399902
81
16
36.39844
null
4.699219
0.399963
0.899902
138
null
null
null
null
0
0
no(M2 and SIP pres)
0
7,997
58.19299
1
male
0
17
49
Colon Cancer
Cancer
1
null
null
0
15,429
11,362.0781
9,369.60938
13.666664
white
6.899414
31
0.920898
0.814941
1
0
0
metastatic
null
null
dnr after sadm
12
104
6.899414
110
24
37.59375
null
4.699219
0.599976
1.299805
131
null
null
null
null
null
null
<2 mo. follow-up
1.877441
7,998
66.47998
0
female
0
21
1,762
MOSF w/Malig
ARF/MOSF
1
8
null
0
39,037
26,767.1094
23,013.8594
19.333328
white
30.597656
35
0.429993
0.310974
13
0
0
yes
0.5
0.25
no dnr
21
103
0.399963
118
24
36.69531
null
2.5
1.199951
0.799927
131
null
null
null
null
null
0
no(M2 and SIP pres)
0
7,999
69.08398
1
male
0
36
38
COPD
COPD/CHF/Cirrhosis
4
null
null
9
61,341
39,997.9062
45,110.875
38.75
white
25.796875
25
0.678955
0.508911
1
0
0
yes
null
null
dnr after sadm
29
70
18
112
9
36.09375
256
2.799805
1.299805
1.099854
143
7.479492
null
null
null
null
null
<2 mo. follow-up
3.189453
8,000
82.05298
1
female
0
27
144
Coma
Coma
3
10
under $11k
44
31,768
22,055.1719
25,770.9688
25.5
white
25.097656
38
0.284973
0.214996
1
0
1
no
0.3
0.1
no dnr
27
74
12.699219
120
36
39.69531
187.09375
3.299805
0.799927
1.199951
137
7.439453
null
null
null
null
1
adl>=4 (>=5 if sur)
1